{"hands_on_practices": [{"introduction": "A cornerstone of genomic diagnostics is the ability to place an individual's genetic profile within the context of global human variation. Principal Component Analysis (PCA) is a powerful method for this, condensing vast genotype data into a few informative dimensions that often correspond to geographic ancestry. This exercise provides a practical walkthrough of projecting a new patient's genotype data onto a pre-built PCA space and using a probabilistic framework to assign continental ancestry, demystifying how abstract genetic coordinates translate into a concrete classification. [@problem_id:4345352]", "problem": "A research-grade ancestry inference pipeline in precision medicine applies Principal Component Analysis (PCA) to Single Nucleotide Polymorphism (SNP) genotype data to obtain low-dimensional population structure coordinates. Let there be $p=5$ SNP features and $k=3$ principal components. The PCA loading matrix $L \\in \\mathbb{R}^{5 \\times 3}$ (columns are orthonormal eigenvectors of the feature covariance) is given by\n$$\nL \\;=\\;\n\\begin{pmatrix}\n\\frac{1}{2} & \\frac{1}{2} & \\frac{1}{\\sqrt{5}} \\\\\n\\frac{1}{2} & -\\frac{1}{2} & -\\frac{1}{\\sqrt{5}} \\\\\n\\frac{1}{2} & \\frac{1}{2} & -\\frac{1}{\\sqrt{5}} \\\\\n\\frac{1}{2} & -\\frac{1}{2} & \\frac{1}{\\sqrt{5}} \\\\\n0 & 0 & \\frac{1}{\\sqrt{5}}\n\\end{pmatrix}.\n$$\nA patient's unphased genotype count vector (number of minor alleles per SNP) is $g \\in \\{0,1,2\\}^{5}$ with\n$$\ng \\;=\\; \\begin{pmatrix} 2 \\\\ 0 \\\\ 1 \\\\ 0 \\\\ 1 \\end{pmatrix},\n$$\nand the global training mean vector of genotypes is\n$$\n\\mu \\;=\\; \\begin{pmatrix} 1.1 \\\\ 1.0 \\\\ 0.9 \\\\ 1.2 \\\\ 0.6 \\end{pmatrix}.\n$$\nThe top-$k$ PCA eigenvalues are\n$$\n\\lambda_{1} \\;=\\; 3.2, \\quad \\lambda_{2} \\;=\\; 1.5, \\quad \\lambda_{3} \\;=\\; 0.9,\n$$\nso the common within-class covariance in PC space is the diagonal matrix\n$$\nS \\;=\\; \\mathrm{diag}\\!\\big(\\lambda_{1}, \\lambda_{2}, \\lambda_{3}\\big).\n$$\nReference continental population centroids (class-conditional means of PC scores) are\n$$\nm_{\\mathrm{AFR}} \\;=\\; \\begin{pmatrix} 2.2 \\\\ 0.1 \\\\ -0.3 \\end{pmatrix}, \\quad\nm_{\\mathrm{EUR}} \\;=\\; \\begin{pmatrix} -1.8 \\\\ 0.4 \\\\ 0.2 \\end{pmatrix}, \\quad\nm_{\\mathrm{EAS}} \\;=\\; \\begin{pmatrix} -2.0 \\\\ -1.0 \\\\ 0.5 \\end{pmatrix}.\n$$\nAssume the following foundational modeling assumptions:\n- Principal Component Analysis (PCA) yields orthonormal loadings, and patient PC scores are the linear projection $s \\;=\\; L^{\\top}(g - \\mu)$.\n- Class-conditional PC scores are distributed as multivariate normal with mean $m_{c}$ and common covariance $S$ for class $c \\in \\{\\mathrm{AFR}, \\mathrm{EUR}, \\mathrm{EAS}\\}$.\n- Prior class probabilities are equal, i.e., $\\pi_{\\mathrm{AFR}} = \\pi_{\\mathrm{EUR}} = \\pi_{\\mathrm{EAS}} \\;=\\; \\frac{1}{3}$.\n\nUsing the definition of Mahalanobis distance $D_{c}^{2} \\;=\\; (s - m_{c})^{\\top} S^{-1} (s - m_{c})$ and Bayes’ rule under the multivariate normal model with equal priors and shared covariance, compute the posterior probability assigned to the maximum a posteriori (MAP) continental ancestry class for this patient (i.e., the soft assignment for the class with the smallest $D_{c}^{2}$). Express your final answer as a decimal and round your answer to four significant figures.", "solution": "The problem is subjected to validation before a solution is attempted.\n\n### Step 1: Extract Givens\n- Number of SNP features, $p=5$.\n- Number of principal components, $k=3$.\n- PCA loading matrix, $L = \\begin{pmatrix} \\frac{1}{2} & \\frac{1}{2} & \\frac{1}{\\sqrt{5}} \\\\ \\frac{1}{2} & -\\frac{1}{2} & -\\frac{1}{\\sqrt{5}} \\\\ \\frac{1}{2} & \\frac{1}{2} & -\\frac{1}{\\sqrt{5}} \\\\ \\frac{1}{2} & -\\frac{1}{2} & \\frac{1}{\\sqrt{5}} \\\\ 0 & 0 & \\frac{1}{\\sqrt{5}} \\end{pmatrix}$.\n- Patient's genotype count vector, $g = \\begin{pmatrix} 2 \\\\ 0 \\\\ 1 \\\\ 0 \\\\ 1 \\end{pmatrix}$.\n- Global training mean vector of genotypes, $\\mu = \\begin{pmatrix} 1.1 \\\\ 1.0 \\\\ 0.9 \\\\ 1.2 \\\\ 0.6 \\end{pmatrix}$.\n- Top-$k$ PCA eigenvalues, $\\lambda_{1} = 3.2$, $\\lambda_{2} = 1.5$, $\\lambda_{3} = 0.9$.\n- Common within-class covariance in PC space, $S = \\mathrm{diag}(\\lambda_{1}, \\lambda_{2}, \\lambda_{3})$.\n- Reference continental population centroids: $m_{\\mathrm{AFR}} = \\begin{pmatrix} 2.2 \\\\ 0.1 \\\\ -0.3 \\end{pmatrix}$, $m_{\\mathrm{EUR}} = \\begin{pmatrix} -1.8 \\\\ 0.4 \\\\ 0.2 \\end{pmatrix}$, $m_{\\mathrm{EAS}} = \\begin{pmatrix} -2.0 \\\\ -1.0 \\\\ 0.5 \\end{pmatrix}$.\n- Modeling Assumptions:\n    - Patient PC scores are $s = L^{\\top}(g - \\mu)$.\n    - The columns of $L$ are orthonormal.\n    - Class-conditional PC scores for class $c \\in \\{\\mathrm{AFR}, \\mathrm{EUR}, \\mathrm{EAS}\\}$ are distributed as a multivariate normal, $s|c \\sim \\mathcal{N}(m_{c}, S)$.\n    - Prior class probabilities are equal, $\\pi_{\\mathrm{AFR}} = \\pi_{\\mathrm{EUR}} = \\pi_{\\mathrm{EAS}} = \\frac{1}{3}$.\n- Definition of Mahalanobis distance squared: $D_{c}^{2} = (s - m_{c})^{\\top} S^{-1} (s - m_{c})$.\n- Task: Compute the posterior probability of the maximum a posteriori (MAP) class and round to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded. The use of PCA on genotype data for population structure inference, followed by classification using a multivariate normal model (specifically, Linear Discriminant Analysis, given the shared covariance matrix), is a standard and well-established procedure in population genetics and precision medicine. The provided data, including the genotype vector, mean vector, eigenvalues, and centroids, are numerically plausible for such a problem. The dimensions of all matrices and vectors are consistent for the prescribed operations. The loading matrix $L$ is explicitly stated to have orthonormal columns, which is a fundamental property of PCA loadings; a manual check confirms that the column vectors are indeed unit vectors and mutually orthogonal. The problem is self-contained, well-posed, and objective, providing all necessary information and clear definitions to arrive at a unique solution.\n\n### Step 3: Verdict and Action\nThe problem is valid. A solution will be provided.\n\n### Solution\nThe objective is to find the posterior probability for the Maximum a Posteriori (MAP) ancestry class for a given patient. According to Bayes' rule, the posterior probability of class $c$ given the patient's PC score vector $s$ is:\n$$ P(c|s) = \\frac{p(s|c) \\pi_c}{p(s)} $$\nwhere $p(s|c)$ is the class-conditional probability density of the scores, $\\pi_c$ is the prior probability of the class, and $p(s) = \\sum_{c'} p(s|c') \\pi_{c'}$ is the marginal probability density of the scores (the evidence).\n\nThe problem states that the class-conditional distribution is a multivariate normal with mean $m_c$ and a common covariance matrix $S$:\n$$ p(s|c) = \\frac{1}{(2\\pi)^{k/2} |S|^{1/2}} \\exp\\left(-\\frac{1}{2} (s - m_{c})^{\\top} S^{-1} (s - m_{c})\\right) $$\nUsing the definition of Mahalanobis distance, $D_{c}^{2} = (s - m_{c})^{\\top} S^{-1} (s - m_{c})$, this becomes:\n$$ p(s|c) = \\frac{1}{(2\\pi)^{k/2} |S|^{1/2}} \\exp\\left(-\\frac{1}{2} D_{c}^{2}\\right) $$\nThe problem also states that the prior probabilities are equal, $\\pi_c = \\frac{1}{3}$. Substituting these into the formula for the posterior probability:\n$$ P(c|s) = \\frac{\\frac{1}{3} \\frac{1}{(2\\pi)^{k/2} |S|^{1/2}} \\exp\\left(-\\frac{1}{2} D_{c}^{2}\\right)}{\\sum_{c'} \\frac{1}{3} \\frac{1}{(2\\pi)^{k/2} |S|^{1/2}} \\exp\\left(-\\frac{1}{2} D_{c'}^{2}\\right)} $$\nThe constant terms $\\frac{1}{3} \\frac{1}{(2\\pi)^{k/2} |S|^{1/2}}$ cancel from the numerator and denominator, simplifying the expression to a softmax function of the negative half Mahalanobis distances:\n$$ P(c|s) = \\frac{\\exp\\left(-\\frac{1}{2} D_{c}^{2}\\right)}{\\sum_{c'} \\exp\\left(-\\frac{1}{2} D_{c'}^{2}\\right)} $$\nThe MAP class, $c_{MAP}$, is the class that maximizes this posterior probability. Maximizing $P(c|s)$ is equivalent to minimizing the Mahalanobis distance squared, $D_c^2$. The solution proceeds in the following steps:\n\n1.  **Compute the centered genotype vector $g' = g - \\mu$:**\n    $$ g' = \\begin{pmatrix} 2 \\\\ 0 \\\\ 1 \\\\ 0 \\\\ 1 \\end{pmatrix} - \\begin{pmatrix} 1.1 \\\\ 1.0 \\\\ 0.9 \\\\ 1.2 \\\\ 0.6 \\end{pmatrix} = \\begin{pmatrix} 0.9 \\\\ -1.0 \\\\ 0.1 \\\\ -1.2 \\\\ 0.4 \\end{pmatrix} $$\n\n2.  **Project the centered vector to obtain the PC scores $s = L^{\\top}g'$:**\n    $$ s = \\begin{pmatrix} \\frac{1}{2} & \\frac{1}{2} & \\frac{1}{2} & \\frac{1}{2} & 0 \\\\ \\frac{1}{2} & -\\frac{1}{2} & \\frac{1}{2} & -\\frac{1}{2} & 0 \\\\ \\frac{1}{\\sqrt{5}} & -\\frac{1}{\\sqrt{5}} & -\\frac{1}{\\sqrt{5}} & \\frac{1}{\\sqrt{5}} & \\frac{1}{\\sqrt{5}} \\end{pmatrix} \\begin{pmatrix} 0.9 \\\\ -1.0 \\\\ 0.1 \\\\ -1.2 \\\\ 0.4 \\end{pmatrix} $$\n    The components of $s$ are:\n    $$ s_1 = \\frac{1}{2}(0.9) + \\frac{1}{2}(-1.0) + \\frac{1}{2}(0.1) + \\frac{1}{2}(-1.2) + 0 = \\frac{1}{2}(0.9 - 1.0 + 0.1 - 1.2) = \\frac{-1.2}{2} = -0.6 $$\n    $$ s_2 = \\frac{1}{2}(0.9) - \\frac{1}{2}(-1.0) + \\frac{1}{2}(0.1) - \\frac{1}{2}(-1.2) + 0 = \\frac{1}{2}(0.9 + 1.0 + 0.1 + 1.2) = \\frac{3.2}{2} = 1.6 $$\n    $$ s_3 = \\frac{1}{\\sqrt{5}}(0.9) - \\frac{1}{\\sqrt{5}}(-1.0) - \\frac{1}{\\sqrt{5}}(0.1) + \\frac{1}{\\sqrt{5}}(-1.2) + \\frac{1}{\\sqrt{5}}(0.4) = \\frac{1}{\\sqrt{5}}(0.9 + 1.0 - 0.1 - 1.2 + 0.4) = \\frac{1.0}{\\sqrt{5}} $$\n    So, the patient's score vector is $s = \\begin{pmatrix} -0.6 \\\\ 1.6 \\\\ \\frac{1}{\\sqrt{5}} \\end{pmatrix}$.\n\n3.  **Compute the Mahalanobis distance squared, $D_c^2$, for each population:**\n    The covariance matrix is $S = \\mathrm{diag}(3.2, 1.5, 0.9)$, so its inverse is $S^{-1} = \\mathrm{diag}(\\frac{1}{3.2}, \\frac{1}{1.5}, \\frac{1}{0.9})$.\n    The formula for $D_c^2$ simplifies to:\n    $$ D_c^2 = \\frac{(s_1 - m_{c,1})^2}{\\lambda_1} + \\frac{(s_2 - m_{c,2})^2}{\\lambda_2} + \\frac{(s_3 - m_{c,3})^2}{\\lambda_3} $$\n    - For $c = \\mathrm{AFR}$ with $m_{\\mathrm{AFR}} = \\begin{pmatrix} 2.2 \\\\ 0.1 \\\\ -0.3 \\end{pmatrix}$:\n      $$ D_{\\mathrm{AFR}}^2 = \\frac{(-0.6 - 2.2)^2}{3.2} + \\frac{(1.6 - 0.1)^2}{1.5} + \\frac{(\\frac{1}{\\sqrt{5}} - (-0.3))^2}{0.9} = \\frac{(-2.8)^2}{3.2} + \\frac{(1.5)^2}{1.5} + \\frac{(\\frac{1}{\\sqrt{5}} + 0.3)^2}{0.9} $$\n      $$ D_{\\mathrm{AFR}}^2 = \\frac{7.84}{3.2} + \\frac{2.25}{1.5} + \\frac{(0.44721... + 0.3)^2}{0.9} = 2.45 + 1.5 + \\frac{(0.74721...)^2}{0.9} \\approx 3.95 + 0.62036 \\approx 4.57036 $$\n    - For $c = \\mathrm{EUR}$ with $m_{\\mathrm{EUR}} = \\begin{pmatrix} -1.8 \\\\ 0.4 \\\\ 0.2 \\end{pmatrix}$:\n      $$ D_{\\mathrm{EUR}}^2 = \\frac{(-0.6 - (-1.8))^2}{3.2} + \\frac{(1.6 - 0.4)^2}{1.5} + \\frac{(\\frac{1}{\\sqrt{5}} - 0.2)^2}{0.9} = \\frac{(1.2)^2}{3.2} + \\frac{(1.2)^2}{1.5} + \\frac{(\\frac{1}{\\sqrt{5}} - 0.2)^2}{0.9} $$\n      $$ D_{\\mathrm{EUR}}^2 = \\frac{1.44}{3.2} + \\frac{1.44}{1.5} + \\frac{(0.44721... - 0.2)^2}{0.9} = 0.45 + 0.96 + \\frac{(0.24721...)^2}{0.9} \\approx 1.41 + 0.06790 \\approx 1.47790 $$\n    - For $c = \\mathrm{EAS}$ with $m_{\\mathrm{EAS}} = \\begin{pmatrix} -2.0 \\\\ -1.0 \\\\ 0.5 \\end{pmatrix}$:\n      $$ D_{\\mathrm{EAS}}^2 = \\frac{(-0.6 - (-2.0))^2}{3.2} + \\frac{(1.6 - (-1.0))^2}{1.5} + \\frac{(\\frac{1}{\\sqrt{5}} - 0.5)^2}{0.9} = \\frac{(1.4)^2}{3.2} + \\frac{(2.6)^2}{1.5} + \\frac{(\\frac{1}{\\sqrt{5}} - 0.5)^2}{0.9} $$\n      $$ D_{\\mathrm{EAS}}^2 = \\frac{1.96}{3.2} + \\frac{6.76}{1.5} + \\frac{(0.44721... - 0.5)^2}{0.9} = 0.6125 + 4.50666... + \\frac{(-0.05278...)^2}{0.9} \\approx 5.11917 + 0.00310 \\approx 5.12227 $$\n\n4.  **Identify the MAP class and compute its posterior probability:**\n    Comparing the squared Mahalanobis distances:\n    $D_{\\mathrm{AFR}}^2 \\approx 4.5704$\n    $D_{\\mathrm{EUR}}^2 \\approx 1.4779$\n    $D_{\\mathrm{EAS}}^2 \\approx 5.1223$\n    The minimum value is $D_{\\mathrm{EUR}}^2$, so the MAP class is EUR.\n\n    Now, we compute the posterior probability for this class, $P(\\mathrm{EUR}|s)$. First, we compute the exponential terms:\n    $$ \\exp\\left(-\\frac{1}{2} D_{\\mathrm{AFR}}^2\\right) = \\exp\\left(-\\frac{4.57036}{2}\\right) = \\exp(-2.28518) \\approx 0.10175 $$\n    $$ \\exp\\left(-\\frac{1}{2} D_{\\mathrm{EUR}}^2\\right) = \\exp\\left(-\\frac{1.47790}{2}\\right) = \\exp(-0.73895) \\approx 0.47760 $$\n    $$ \\exp\\left(-\\frac{1}{2} D_{\\mathrm{EAS}}^2\\right) = \\exp\\left(-\\frac{5.12227}{2}\\right) = \\exp(-2.56114) \\approx 0.07722 $$\n    The sum in the denominator is:\n    $$ \\sum_{c'} \\exp\\left(-\\frac{1}{2} D_{c'}^{2}\\right) \\approx 0.10175 + 0.47760 + 0.07722 = 0.65657 $$\n    The posterior probability of the MAP class (EUR) is:\n    $$ P(\\mathrm{EUR}|s) = \\frac{0.47760}{0.65657} \\approx 0.727402... $$\n\n5.  **Final Answer:**\n    Rounding the result to four significant figures gives $0.7274$.", "answer": "$$\\boxed{0.7274}$$", "id": "4345352"}, {"introduction": "The effectiveness of ancestry inference methods, such as the PCA-based approach in the previous exercise, hinges on the selection of genetic markers that exhibit substantial frequency differences among populations. The fixation index, $F_{ST}$, is the canonical metric in population genetics for quantifying this allele frequency differentiation. By calculating $F_{ST}$ for a single nucleotide polymorphism (SNP) in a pharmacogenomically important gene, you will learn how to quantitatively assess whether a genetic locus qualifies as a useful Ancestry Informative Marker (AIM) for clinical stratification. [@problem_id:4345375]", "problem": "A health system is implementing a precision dosing program for warfarin that integrates genetic ancestry into pharmacogenomic decision support. Consider a biallelic single-nucleotide polymorphism (SNP) in the vitamin K epoxide reductase complex subunit $1$ gene, where the variant allele $V$ frequency differs across two source populations used to infer genetic ancestry components. Population $\\mathcal{A}$ has allele $V$ frequency $p_{\\mathcal{A}} = 0.78$ with sample size $n_{\\mathcal{A}} = 500$, and Population $\\mathcal{B}$ has allele $V$ frequency $p_{\\mathcal{B}} = 0.12$ with sample size $n_{\\mathcal{B}} = 500$. Assume Hardy–Weinberg Equilibrium (HWE) within each population and random mating within but not between populations. Using the foundational definition of the fixation index (the proportion of total gene diversity attributable to allele frequency differences among subpopulations), compute the fixation index $F_{ST}$ at this locus for the two-population system. Then, interpret whether this locus is ancestry informative for clinical stratification in the context of pharmacogenomics. Express the final $F_{ST}$ as a decimal and round your numerical answer to four significant figures.", "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective.\n\n### Step 1: Extract Givens\n- Analyte: A biallelic single-nucleotide polymorphism (SNP) in the vitamin K epoxide reductase complex subunit $1$ gene.\n- Alleles: A variant allele $V$ and an alternative (wild-type) allele.\n- Population $\\mathcal{A}$:\n    - Frequency of allele $V$: $p_{\\mathcal{A}} = 0.78$.\n    - Sample size: $n_{\\mathcal{A}} = 500$.\n- Population $\\mathcal{B}$:\n    - Frequency of allele $V$: $p_{\\mathcal{B}} = 0.12$.\n    - Sample size: $n_{\\mathcal{B}} = 500$.\n- Assumptions:\n    1. Hardy–Weinberg Equilibrium (HWE) holds within each population.\n    2. Random mating occurs within each population, but not between them.\n- Task:\n    1. Compute the fixation index, $F_{ST}$, defined as the proportion of total gene diversity attributable to allele frequency differences among subpopulations.\n    2. Interpret whether the locus is ancestry informative for clinical stratification.\n- Formatting Requirement: Express the final $F_{ST}$ value as a decimal rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically sound. It uses standard concepts and terminology from population genetics, such as SNPs, allele frequencies, Hardy-Weinberg Equilibrium, and the fixation index ($F_{ST}$). The application to the pharmacogenomics of warfarin, specifically involving the VKORC1 gene, is a canonical example in precision medicine. The provided allele frequencies ($0.78$ and $0.12$) are realistic for different human populations. The problem is well-posed, providing all necessary data and a clear definition to calculate $F_{ST}$. The language is objective and formal. The problem does not violate any of the invalidity criteria.\n\n### Step 3: Verdict and Action\nThe problem is valid. A complete solution will be provided.\n\n### Solution Derivation\nThe primary objective is to calculate the fixation index, $F_{ST}$, for the two-population system described. The problem defines $F_{ST}$ as the proportion of total genetic diversity (heterozygosity) that is due to differences in allele frequencies between subpopulations. This is mathematically expressed as:\n$$F_{ST} = \\frac{H_T - H_S}{H_T}$$\nwhere:\n- $H_T$ is the total expected heterozygosity in the combined population, calculated under the assumption of random mating.\n- $H_S$ is the average of the expected heterozygosities within the subpopulations.\n\nLet $p$ be the frequency of the variant allele $V$ and $q$ be the frequency of the alternative allele. Since the locus is biallelic, $q = 1 - p$. The expected heterozygosity in a population at HWE is given by $2pq$.\n\n**1. Calculation of $H_S$, the average subpopulation heterozygosity**\n\nFirst, we calculate the expected heterozygosity for each population, $H_{\\mathcal{A}}$ and $H_{\\mathcal{B}}$.\nFor Population $\\mathcal{A}$, the allele frequencies are $p_{\\mathcal{A}} = 0.78$ and $q_{\\mathcal{A}} = 1 - p_{\\mathcal{A}} = 1 - 0.78 = 0.22$.\nThe expected heterozygosity is:\n$$H_{\\mathcal{A}} = 2 p_{\\mathcal{A}} q_{\\mathcal{A}} = 2(0.78)(0.22) = 0.3432$$\nFor Population $\\mathcal{B}$, the allele frequencies are $p_{\\mathcal{B}} = 0.12$ and $q_{\\mathcal{B}} = 1 - p_{\\mathcal{B}} = 1 - 0.12 = 0.88$.\nThe expected heterozygosity is:\n$$H_{\\mathcal{B}} = 2 p_{\\mathcal{B}} q_{\\mathcal{B}} = 2(0.12)(0.88) = 0.2112$$\n$H_S$ is the weighted average of the subpopulation heterozygosities. The weights are the relative sizes of the populations. Since the sample sizes are equal ($n_{\\mathcal{A}} = n_{\\mathcal{B}} = 500$), $H_S$ is the simple arithmetic mean of $H_{\\mathcal{A}}$ and $H_{\\mathcal{B}}$:\n$$H_S = \\frac{n_{\\mathcal{A}} H_{\\mathcal{A}} + n_{\\mathcal{B}} H_{\\mathcal{B}}}{n_{\\mathcal{A}} + n_{\\mathcal{B}}} = \\frac{500 \\cdot H_{\\mathcal{A}} + 500 \\cdot H_{\\mathcal{B}}}{500 + 500} = \\frac{H_{\\mathcal{A}} + H_{\\mathcal{B}}}{2}$$\n$$H_S = \\frac{0.3432 + 0.2112}{2} = \\frac{0.5544}{2} = 0.2772$$\n\n**2. Calculation of $H_T$, the total population heterozygosity**\n\nTo calculate $H_T$, we first need the average allele frequency of $V$, denoted by $\\bar{p}$, across the total population. This is the weighted average of the subpopulation allele frequencies.\n$$\\bar{p} = \\frac{n_{\\mathcal{A}} p_{\\mathcal{A}} + n_{\\mathcal{B}} p_{\\mathcal{B}}}{n_{\\mathcal{A}} + n_{\\mathcal{B}}}$$\nGiven $n_{\\mathcal{A}} = n_{\\mathcal{B}} = 500$, this simplifies to:\n$$\\bar{p} = \\frac{p_{\\mathcal{A}} + p_{\\mathcal{B}}}{2} = \\frac{0.78 + 0.12}{2} = \\frac{0.90}{2} = 0.45$$\nThe average frequency of the other allele, $\\bar{q}$, is:\n$$\\bar{q} = 1 - \\bar{p} = 1 - 0.45 = 0.55$$\n$H_T$ is the expected heterozygosity if the total population were a single, randomly mating unit. It is calculated using the average allele frequencies:\n$$H_T = 2 \\bar{p} \\bar{q} = 2(0.45)(0.55) = 0.4950$$\n\n**3. Calculation of $F_{ST}$**\n\nNow we can substitute the values of $H_T$ and $H_S$ into the formula for $F_{ST}$:\n$$F_{ST} = \\frac{H_T - H_S}{H_T} = \\frac{0.4950 - 0.2772}{0.4950} = \\frac{0.2178}{0.4950} = 0.44$$\nThe problem requires the answer to be rounded to four significant figures.\n$$F_{ST} = 0.4400$$\n\n**4. Interpretation of the $F_{ST}$ Value**\n\nThe fixation index, $F_{ST}$, ranges from $0$ to $1$. A value of $0$ indicates no genetic differentiation between populations, while a value of $1$ indicates that the populations are fixed for different alleles. The calculated value is $F_{ST} = 0.4400$.\n\nBy convention, $F_{ST}$ values are often interpreted as follows:\n- $0$ to $0.05$: little genetic differentiation.\n- $0.05$ to $0.15$: moderate genetic differentiation.\n- $0.15$ to $0.25$: great genetic differentiation.\n- Greater than $0.25$: very great genetic differentiation.\n\nAn $F_{ST}$ of $0.4400$ signifies very great genetic differentiation at this SNP locus between Population $\\mathcal{A}$ and Population $\\mathcal{B}$. This means that a large proportion ($44\\%$) of the total genetic variation at this locus is explained by the frequency differences between the two populations.\n\nFor a locus to be \"ancestry informative,\" it must show substantial allele frequency differences among populations. The high $F_{ST}$ value confirms that this SNP is an excellent ancestry-informative marker (AIM). In the context of clinical stratification for pharmacogenomics, this is highly relevant. Knowledge of a patient's genetic ancestry (i.e., the proportion of their genome originating from populations like $\\mathcal{A}$ or $\\mathcal{B}$) can be used to predict their genotype at this locus with significant probability. For warfarin dosing, where the VKORC1 genotype is a critical determinant of response, using this AIM as part of a dosing algorithm can improve the safety and efficacy of the initial dose, which is the core principle of precision dosing.", "answer": "$$\\boxed{0.4400}$$", "id": "4345375"}, {"introduction": "Failing to account for genetic ancestry can have profound consequences in clinical research, leading to spurious associations and incorrect conclusions. This is particularly true in genome-wide association studies (GWAS), where subtle population structure can systematically inflate test statistics, increasing the rate of false-positive findings. This problem introduces the genomic inflation factor ($\\lambda$) as a critical quality control metric to diagnose such biases, allowing you to assess whether statistical corrections for ancestry in a study design have been adequate. [@problem_id:4345299]", "problem": "A genome-wide association study (GWAS) was conducted in an admixed case-control cohort with $N_{\\text{cases}} = 5{,}000$ and $N_{\\text{controls}} = 5{,}000$, where global ancestry proportions were estimated via supervised admixture analysis and individual-level principal components (PCs) were inferred using singular value decomposition of linkage disequilibrium-pruned genotypes. Logistic regression was used to test per-marker association with disease status, including covariates for age, sex, and the top $10$ ancestry PCs. To assess residual confounding by genetic ancestry and control of the type I error rate, the distribution of per-marker Wald test statistics was summarized across $600{,}000$ linkage disequilibrium-pruned autosomal variants with minor allele frequency greater than $0.05$, after excluding the top $1{,}000$ lowest $p$-values to reduce the influence of true signals.\n\nAssume the following foundational facts and definitions:\n- Under the null hypothesis of no association and correct model specification, the per-marker Wald test statistic for a single regression coefficient asymptotically follows a chi-square distribution with one degree of freedom, denoted $\\chi^{2}_{1}$.\n- Let $m_{0.5}$ denote the median of the $\\chi^{2}_{1}$ distribution, defined as the unique $x$ satisfying $F_{\\chi^{2}_{1}}(x) = 0.5$. A well-established numerical value is $m_{0.5} \\approx 0.454936$.\n- The genomic inflation factor $\\lambda$ is a scale measure of deviation of observed test statistics from their null distribution, defined as the ratio of the empirical median of observed null test statistics to $m_{0.5}$.\n\nIn this study, the empirical median of the Wald $\\chi^{2}$ test statistics after the ancestry correction described above was $0.492$.\n\nStarting from the asymptotic null distribution and the definition of the genomic inflation factor, compute $\\lambda$ using the provided quantities. Then, based on the value of $\\lambda$, reason whether the ancestry correction methods appear to adequately control the type I error rate for this design. Provide the numerical value of $\\lambda$ as your final answer and round to three significant figures. No units are required for the final answer.", "solution": "The problem requires the calculation of the genomic inflation factor, denoted by the symbol $\\lambda$, and an assessment of its implications for the control of type I error in a genome-wide association study (GWAS).\n\nUnder the null hypothesis ($H_0$) of no true association between a genetic marker and the disease phenotype, the test statistics across all markers are expected to follow a specific theoretical probability distribution. In this case, the problem states that the Wald test statistic for a single regression coefficient, let us denote it as $T$, is expected to asymptotically follow a chi-square distribution with one degree of freedom, written as $T \\sim \\chi^{2}_{1}$.\n\nThe genomic inflation factor, $\\lambda$, is a diagnostic metric used to quantify the extent to which the observed distribution of test statistics deviates from the expected null distribution. It is formally defined as the ratio of the median of the empirically observed test statistics to the median of the theoretical null distribution. The use of the median is crucial as it is robust to the influence of a small number of markers that exhibit true association (i.e., true positives), which would otherwise skew the mean of the distribution. To further ensure that the empirical median reflects the behavior of null markers, the problem specifies that the top $1{,}000$ most significant associations (lowest $p$-values) were excluded from this calculation.\n\nLet $T_{\\text{obs}}$ represent the set of observed Wald test statistics from the GWAS. The empirical median is denoted as $\\text{median}(T_{\\text{obs}})$. The theoretical median of the $\\chi^{2}_{1}$ distribution is denoted by $m_{0.5}$. The definition of $\\lambda$ is therefore:\n$$\n\\lambda = \\frac{\\text{median}(T_{\\text{obs}})}{m_{0.5}}\n$$\nThe problem provides the necessary quantities for this calculation:\n1. The empirical median of the observed Wald $\\chi^{2}$ test statistics is given as $\\text{median}(T_{\\text{obs}}) = 0.492$.\n2. The theoretical median of the $\\chi^{2}_{1}$ distribution is given as $m_{0.5} \\approx 0.454936$.\n\nSubstituting these values into the definition of $\\lambda$:\n$$\n\\lambda = \\frac{0.492}{0.454936} \\approx 1.081471\n$$\nThe problem asks for the result to be rounded to three significant figures.\n$$\n\\lambda \\approx 1.08\n$$\n\nNow, we must interpret this value. A $\\lambda$ value of exactly $1.0$ would indicate that the median of the observed test statistics perfectly matches the median expected under the null hypothesis. This is the ideal scenario, suggesting that systematic biases, particularly population stratification, have been successfully controlled.\n\nThe calculated value is $\\lambda \\approx 1.08$. This value is greater than $1.0$, indicating that the observed test statistics are, on the whole, larger than what would be expected by chance. This phenomenon is known as \"inflation\" of the test statistics. Such inflation can arise from several sources, including uncorrected population structure, cryptic relatedness among study participants, or other technical artifacts in genotyping or analysis. Inflation of test statistics leads to a systematic deviation of the $p$-value distribution from the expected uniform distribution under the null, resulting in an elevated rate of false-positive findings (an increased type I error rate).\n\nWhile a value of $\\lambda$ close to $1.0$ (e.g., $\\lambda \\le 1.05$) is often considered indicative of adequate control in large-scale GWAS, a value of $1.08$ suggests that the implemented ancestry correction—including the top $10$ principal components (PCs) as covariates—has not completely accounted for all the confounding due to population structure. There appears to be some residual inflation. Therefore, the ancestry correction methods, while likely mitigating a substantial portion of the confounding, do not appear to have *fully* or *adequately* controlled the inflation of the type I error rate. The study may still suffer from a slightly higher than nominal rate of false positives. Investigators might consider exploring more stringent correction methods, such as including more PCs or applying a linear mixed model approach, to better control this residual inflation.", "answer": "$$\n\\boxed{1.08}\n$$", "id": "4345299"}]}